<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64197</article-id><article-id pub-id-type="doi">10.17816/dv64197</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Combination of isotretinoin and Contractubex Anti-Red in acne therapy</article-title><trans-title-group xml:lang="ru"><trans-title>Тандем изотретиноина и геля Контрактубекс Анти-Ред в терапии акне</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4537-401X</contrib-id><contrib-id contrib-id-type="spin">8935-3537</contrib-id><name-alternatives><name xml:lang="en"><surname>Katkhanova</surname><given-names>Olga A.</given-names></name><name xml:lang="ru"><surname>Катханова</surname><given-names>Ольга Алиевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>okathanova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7625-0503</contrib-id><name-alternatives><name xml:lang="en"><surname>Grigoryants</surname><given-names>Svetlana A.</given-names></name><name xml:lang="ru"><surname>Григорянц</surname><given-names>Светлана Анушавановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student</p></bio><bio xml:lang="ru"><p>аспирант</p></bio><email>svetulya2597@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8512-3736</contrib-id><name-alternatives><name xml:lang="en"><surname>Glazko</surname><given-names>Irina I.</given-names></name><name xml:lang="ru"><surname>Глазко</surname><given-names>Ирина Ивановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.), Associate Professor</p></bio><bio xml:lang="ru"><p>к.м.н., доцент</p></bio><email>irinap17@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Rostov State Medical University</institution></aff><aff><institution xml:lang="ru">Ростовский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kuban State Medical University</institution></aff><aff><institution xml:lang="ru">Кубанский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Burnasyan Federal Medical Biophysical Center</institution></aff><aff><institution xml:lang="ru">Федеральный медицинский биофизический центр им. А.И. Бурназяна</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2021</year></pub-date><volume>24</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>285</fpage><lpage>296</lpage><history><date date-type="received" iso-8601-date="2021-03-25"><day>25</day><month>03</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-20"><day>20</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО "Эко-Вектор"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-08-01"/></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/64197">https://rjsvd.com/1560-9588/article/view/64197</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND:</italic></bold> Acne vulgaris (acne vulgaris) is an urgent interdisciplinary problem. Analyzing modern scientific data on the development of acne vulgaris, it is necessary to focus on the role of inflammation that accompanies dermatosis at all its stages of development, sometimes preceding the formation of clinical symptoms. Prolonged chronic recurrent course, difficulties in choosing the correct therapy tactics, sometimes unreasonable medical interventions, exacerbation, improper skin care lead to the formation of a number of complications.</p> <p><bold><italic>AIMS:</italic></bold> To optimize and improve the effectiveness of therapy in patients with moderate and severe degrees acne using isotretinoin and the combined innovative gel Contractubex Anti-Red.</p> <p><bold><italic>MATERIALS AND METHODS:</italic></bold> The study included 60 patients aged 18 to 45 years with moderate to severe acne. Isotretinoin was prescribed in standard dosages. To study the effect of Contraktubex Anti-Red on the dynamics of post-acne, patients with atrophic post-acne scars were divided into 3 subgroups, depending on the regimen of drug use.</p> <p><bold><italic>RESULTS:</italic></bold> Almost complete relief of the inflammatory process, regression of elements was noted 12 months after the use of complex therapy, the value of the dermanologic index of acne (DIA) index was more than 70% noted in 62% of patients, significant improvement in 38%. The severity of post-acne scars on the SCAR-S scale changed significantly during treatment and in 53.3% this indicator was 1. The Cadi index decreased by 70% compared to the baseline.</p> <p><bold><italic>CONCLUSION:</italic></bold> Good cosmetic effect, safety, absence of side effects, comfort and ease of use make it possible to recommend Contractubex Anti-Red together with basic acne therapy.</p></abstract><trans-abstract xml:lang="ru"><p><bold><italic>Обоснование.</italic></bold> Акне вульгарные (<italic>acne vulgaris</italic>) ― актуальная междисциплинарная проблема. Анализируя современные научные данные о развитии <italic>acne vulgaris</italic>, необходимо сделать акцент на роли воспаления, которое сопровождает дерматоз на всех его этапах развития, иногда предшествуя формированию клинических симптомов. Длительное хроническое рецидивирующее течение, трудности в выборе правильной тактики терапии, порой необоснованные медицинские вмешательства, экзацербация, неправильный уход за кожей приводят к формированию целого ряда осложнений.</p> <p><bold><italic>Цель </italic></bold>― оптимизация и повышение эффективности терапии пациентов со средней и тяжёлой степенью акне с использованием изотретиноина и комбинированного геля Контрактубекс Анти-Ред.</p> <p><bold><italic>Материал и методы.</italic></bold> Под нашим наблюдением в Клинике Екатерининская находилось 60 пациентов в возрастном диапазоне от 18 до 45 лет со средним и тяжёлым течением акне. Изотретиноин назначали в стандартных дозировках. Для изучения влияния Контрактубекс Анти-Ред на динамику постакне пациенты с атрофическими рубцами были распределены в 3 подгруппы в зависимости от схемы применения препарата.</p> <p><bold><italic>Результаты.</italic></bold> Практически полное купирование воспалительного процесса и регресс элементов наблюдались через 12 мес после применения комплексной терапии; значение дерматологического индекса акне &gt;70% отмечено у 62% пациентов, значительное улучшение ― у 38%. Степень тяжести рубцов постакне по шкале SCAR-S в процессе лечения значительно изменилась, и у 53,3% этот показатель составил 1. Индекс CADI снизился на 70% по сравнению с исходными показателями.</p> <p><bold><italic>Заключение.</italic></bold> Хороший косметический эффект, безопасность, отсутствие побочных эффектов, комфортность и удобство применения позволяют рекомендовать Контрактубекс Анти-Ред совместно с базовыми средствами терапии акне.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acne</kwd><kwd>post-acne</kwd><kwd>therapy</kwd><kwd>scars</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>акне</kwd><kwd>постакне</kwd><kwd>терапия</kwd><kwd>рубцы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Dreno B, Layton A, Zouboulis C, et al. Adult female acne:a new paradigm. J Eur Acad Dermatol Venereol. 2013;27(9):1063–1070. doi: 10.1111/jdv.12061</mixed-citation><mixed-citation xml:lang="ru">Dreno B., Layton A., Zouboulis C., et al. Adult female acne: a new paradigm // J Eur Acad Dermatol Venereol. 2013. Vol. 27, N 9. P. 1063–1070. doi: 10.1111/jdv.12061</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Thiboutot DM, Dreno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from Global Alliance to improve outcomes in acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1–S23. doi: 10.1016/j.jaad.2017.09.078</mixed-citation><mixed-citation xml:lang="ru">Thiboutot D.M., Dreno B., Abanmi A., et al. Practical management of acne for clinicians: an international consensus from Global Alliance to improve outcomes in acne // J Am Acad Dermatol. 2018. Vol. 78, N 2, Suppl 1. P. S1–S23. doi: 10.1016/j.jaad.2017.09.078</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Demina OM, Potekaev NN, Kartelishev AV. Clinical and pathogenetic features and methods of therapy of late forms of acne in women. Clinical Dermatology and Venereology. 2015;14(6):133–137. (In Russ). doi: 10.17116/klinderma2015146133-137</mixed-citation><mixed-citation xml:lang="ru">Демина О.М., Потекаев Н.Н., Картелишев А.В. Клинико-патогенетические особенности и методы терапии поздних форм угревой болезни у женщин // Клиническая дерматология и венерология. 2015. Т. 14, № 6. С. 133–137. doi: 10.17116/klinderma2015146133-137</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Lvov AN, Kornyat MS, Igoshina AV, Nazarenko AR. Perspectives in acne therapy: an analytical review. Klinicheskaya Dermatologiya i Venerologiya. 2019;18(2):115–128. doi: 10.17116/klinderma201918021115</mixed-citation><mixed-citation xml:lang="ru">Lvov A.N., Kornyat M.S., Igoshina A.V., Nazarenko A.R. Perspectives in acne therapy: an analytical review // Klinicheskaya dermatologiya i venerologiya. 2019. Vol. 18, N 2. P. 115–128. doi: 10.17116/klinderma201918021115</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Nast A, Dréno B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne-update 2016: short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268. doi: 10.1111/jdv.13776</mixed-citation><mixed-citation xml:lang="ru">Nast A., Dréno B., Bettoli V., et al. European evidence-based (S3) guideline for the treatment of acne-update 2016: short version // J Eur Acad Dermatol Venereol. 2016. Vol. 30, N 8. P. 1261–1268. doi: 10.1111/jdv.13776</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Carlavan I, Bertino B, Rivier M, et al. Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands. Br J Dermatol. 2018;179(4):906–917. doi: 10.1111/bjd.16680</mixed-citation><mixed-citation xml:lang="ru">Carlavan I., Bertino B., Rivier M., et al. Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands // Br J Dermatol. 2018. Vol. 179, N 4. P. 906–917. doi: 10.1111/bjd.16680</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Hayashi N, Miyachi Y, Kawashima M. Prevalence of scars and “Mini-Scars”, and their impact on quality of life in Japanese patients with acne. J Dermatol. 2015;42(7):690–696. doi: 10.1111/1346-8138.12885</mixed-citation><mixed-citation xml:lang="ru">Hayashi N., Miyachi Y., Kawashima M. Prevalence of scars and “Mini-Scars”, and their impact on quality of life in Japanese patients with acne // J Dermatol. 2015. Vol. 42, N 7. P. 690–696. doi: 10.1111/1346-8138.12885</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Ufimtseva MA, Simonova NV, Bochkarev YM, et al. Methods of clinical assessment and treatment of post-acne atrophic scars. Modern Problems of Science and Education. 2020;(2):166. (In Russ). doi: 10.17513/spno.29704</mixed-citation><mixed-citation xml:lang="ru">Уфимцева М.А., Симонова Н.В., Бочкарев Ю.М., и др. Методы клинической оценки и лечения атрофических рубцов постакне // Современные проблемы науки и образования. 2020. № 2. С. 166. doi: 10.17513/spno.29704</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45(1):109–117. doi: 10.1067/mjd.2001.113451</mixed-citation><mixed-citation xml:lang="ru">Jacob C.I., Dover J.S., Kaminer M.S. Acne scarring: a classification system and review of treatment options // J Am Acad Dermatol. 2001. Vol. 45, N 1. P. 109–117. doi: 10.1067/mjd.2001.113451</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Clark AK, Saric S, Sivamani RK. Acne scars: how do we grade them? Am J Clin Dermatol. 2018;19(2):139–144. doi: 10.1007/s40257-017-0321-x</mixed-citation><mixed-citation xml:lang="ru">Clark A.K., Saric S., Sivamani R.K. Acne scars: how do we grade them? // Am J Clin Dermatol. 2018. Vol. 19, N 2. P. 139–144. doi: 10.1007/s40257-017-0321-x</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Kang S, Lozada VT, Bettoli V, et al. New atrophic acne scar classification: reliability of assessments based on size, shape, and number. J Drugs Dermatol. 2016;15(6):693–702.</mixed-citation><mixed-citation xml:lang="ru">Kang S., Lozada V.T., Bettoli V., et al. New atrophic acne scar classification: reliability of assessments based on size, shape, and number // J Drugs Dermatol. 2016. Vol. 15, N 6. Р. 693–702.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Sanakoeva EG. Multifactorial analysis of the features of the course, diagnosis and treatment of acne of moderate and severe severity as a basis for improving the quality of medical care [dissertation abstract]. Moscow; 2019. 27 p. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Санакоева Э.Г. Многофакторный анализ особенностей течения, диагностики и лечения акне средней и тяжелой степеней тяжести как основа совершенствования качества медицинской помощи: Автореф. дис. … докт. мед. наук. Москва, 2019. 27 с.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Tolstaya AI, Zilberberg NV. The effectiveness of ablative fractional photothermolysis in the complex therapy of inflammatory acne and atrophic post-acne scars. Modern Problems of Dermatovenerology, Immunology and Medical Cosmetology. 2013;(4):41–49. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Толстая А.И., Зильберберг Н.В. Эффективность аблятивного фракционного фототермолиза в комплексной терапии воспалительных акне и атрофических рубцов постакне // Современные проблемы дерматовенерологии, иммунологии и врачебной косметологии. 2013. Т. 8, № 4. С. 41–49.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol Surg. 2006;32(12):1458–1466. doi: 10.1111/j.1524-4725.2006.32354.x</mixed-citation><mixed-citation xml:lang="ru">Goodman G.J., Baron J.A. Postacne scarring: a qualitative global scarring grading system // Dermatol Surg. 2006. Vol. 32, N 12. Р. 1458–1466. doi: 10.1111/j.1524-4725.2006.32354.x</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Katkhanova OA, Katkhanov AM. Acne from the position of a dermatologist and cosmetologist. Bulletin of Dermatology and Venereology. 2014;90(4):75–82. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Катханова О.А., Катханов А.М. Акне с позиции дерматолога и косметолога // Вестник дерматологии и венерологии. 2014. Т. 90, № 4. С. 75–82.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Katkhanova ОА, Katkhanov АM. The experience in the use of topical retinoids and azelaic acid in therapy of acne. Klinicheskaya Dermatologia i Venerologia. 2015;(6):120–125. doi: 10.17116/klinderma2015146120-125</mixed-citation><mixed-citation xml:lang="ru">Katkhanova О.А., Katkhanov А.M. The experience in the use of topical retinoids and azelaic acid in therapy of acne // Klinicheskaya Dermatologia I Venerologia. 2015. № 6. С. 120–125. doi: 10.17116/klinderma2015146120-125</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Kochergin NA, Samgin MA, Monakhov SA, Ignatiev D. Dermatological index of acne. Aesthetic Medicine. 2004;3(1):62–65.</mixed-citation><mixed-citation xml:lang="ru">Кочергин Н.А., Самгин М.А., Монахов С.А., Игнатьев Д. Дерматологический индекс акне // Эстетическая медицина. 2004. Т. 3, № 1. С. 62–65.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Tan JK, Tang J, Fung K, et al. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk. J Cutan Med Surg. 2010;14(4):156–160. doi: 10.2310/7750.2010.09037</mixed-citation><mixed-citation xml:lang="ru">Tan J.K., Tang J., Fung K., et al. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk // J Cutan Med Surg. 2010. Vol. 14, N 4. Р. 156–160. doi: 10.2310/7750.2010.09037</mixed-citation></citation-alternatives></ref></ref-list></back></article>
